Table 1 Measles cases in the 10 years following the ESEN2 serological study, and mean estimated population immunity (contact-adjusted or not, with fixed R0 and equivocal samples interpreted as positive) based on the study and adjusted for vaccination uptake
| Â | Cases | Immunity | ||||
|---|---|---|---|---|---|---|
Country | Total (10 years) | Maximum annual | Mean annual (per million) | Maximum annual (per million) | Contact-adjusted | Plain |
Slovakia | 2 | 2 | 0.037 | 0.37 | 0.96 | 0.96 |
Hungary | 12 | 5 | 0.12 | 0.5 | 0.95 | 0.95 |
Czech Republic | 84 | 30 | 0.82 | 2.9 | 0.98 | 0.98 |
Latvia | 16 | 7 | 0.72 | 3.1 | 0.71 | 0.82 |
Sweden | 210 | 62 | 2.4 | 7 | 0.94 | 0.94 |
Lithuania | 58 | 35 | 1.7 | 10 | 0.91 | 0.93 |
Slovenia | 26 | 22 | 1.3 | 11 | 0.96 | 0.96 |
Malta | 14 | 6 | 3.5 | 15 | 0.93 | 0.95 |
Luxembourg | 10 | 8 | 2.3 | 18 | 0.95 | 0.96 |
UK | 6001 | 1445 | 10 | 25 | 0.92 | 0.96 |
Spain | 3419 | 1842 | 8.6 | 46 | 0.95 | 0.98 |
Belgium | 1066 | 576 | 10 | 56 | 0.85 | 0.94 |
Cyprus | 111 | 90 | 11 | 87 | 0.84 | 0.93 |
Ireland | 1687 | 443 | 40 | 105 | 0.88 | 0.91 |
Israel | 1792 | 931 | 30 | 155 | 0.94 | 0.95 |
Romania | 20570 | 7450 | 93 | 337 | 0.92 | 0.96 |
Bulgaria | 24416 | 22004 | 305 | 2750 | 0.82 | 0.88 |